1. HBW Insight
  2. >>Leadership

Beautycounter Founder Returns As CEO; Inter Parfum’s FY2023 Results; Cosmetics News

 
• By Eileen Francis

Gregg Renfrew will start as CEO at the company she founded on 1 February. Separately, International Flavors & Fragrances taps J. Erik Fyrwald to succeed Frank Clyburn as CEO, Inter Parfums reports fiscal 2023 full-year results, Yellow Wood Partners acquires Chapstick, and more.

Woman announcing
• Source: Shutterstock

Beautycounter founder Gregg Renfrew will return to the company as CEO after selling the business in 2021 to the Carlyle Group, announces Counter Brands, LLC, a division of the private equity firm. In a 19 January release, the Santa Monica-based firm notes Renfrew, who will replace interim CEO and board director Mindy Mackenzie, will assume the role on 1 February. Counter Brands reported it was seeking a permanent replacement last summer. (Also see "L’Oreal Bets On Biotech; Beautycounter Launches CEO Search; NIVEA ‘Skin Out Loud’; Cosmetics News" - HBW Insight, 7 June, 2023.)

“We are thrilled to welcome back Gregg to lead Beautycounter in this important next phase of growth. Gregg, as the founder and inspiration of Beautycounter’s mission, also has a proven track record at the company for driving results and engaging both advocates and associates who work alongside her to make meaningful change,” says board chair Robert Marques

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

People On The Move: Appointments At Haleon, Wellnex, Orkla

 
• By Tom Gallen

A round-up of the latest consumer health leadership changes: Haleon names Middle East & Africa unit manager; Wellnex Life appoints interim chair; Orkla Health appoints CEO.

Over The Counter: Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer

 
• By David Ridley

HBW Insight finds out all about real world evidence and its potential for the OTC industry by chatting with IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer.

Makary’s Reorganization Decision A Turning Point For US FDA?

 
• By Michael McCaughan

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

US FDA Retirements Continue Unabated With Drug Inspectorate Leaders, Former Chief Counsel

 
• By Sue Sutter and Derrick Gingery

Alonza Cruse, director of the Office of Human and Animal Drugs Inspectorate, and two other senior inspection officials are departing, along with Mark Raza, chief counsel from 2021 until January.

More from HBW Insight

Global Alliance Urges UN General Assembly To Put Self-Care At Centre Of NCD Strategy

 
• By David Ridley

Including self-care in an upcoming UN General Assembly political declaration would be a “powerful signal that the global community is serious about non-communicable disease prevention and control,” argues the United for Self-Care Coalition, which includes the Global Self-Care Federation, International Self-Care Foundation and Imperial College London’s Self-Care Academic Research Unit.

Danes Get OTC Access To ED Treatment

 
• By Tom Gallen

Navamedic has launched Eroxon in Danish pharmacies giving men in the country OTC access to an ED treatment for the first time.

Perrigo Sees Growth Opportunities In Tariff Storm

 
• By Malcolm Spicer

As largest provider of private label/store brand OTCs with “100 plus molecules across 100% price point coverage,” CEO Patrick Lockwood-Taylor says Perrigo’s in position to capitalize as consumers become “more cautious” and look for lower-priced products.